The analysis of the effectiveness and safety of levofloxacin in the treatment of lower respiratory tract infection.

Ibrahim Alreshidi, Khalid M. Al-Mutairi, Xie Han
{"title":"The analysis of the effectiveness and safety of levofloxacin in the treatment of lower respiratory tract infection.","authors":"Ibrahim Alreshidi, Khalid M. Al-Mutairi, Xie Han","doi":"10.3329/ICPJ.V4I12.25598","DOIUrl":null,"url":null,"abstract":"Objective of the current study was to investigate the effectiveness and safety of levofloxacin in the treatment of lower respiratory tract infection. The study was carried out in hospital on 120 patients with lower respiratory tract infection from January 2014 to January 2015. Patients were randomly divided into control and observation groups, each group contained 60 patients. The control group was given the routine dose of levofloxacin, whereas the observation group received the high dose of levofloxacin. The clinical effectiveness and incidence rate of untoward reactions between the two groups were statistically analyzed and evaluated. Patients’ cure rate in the observation group was 53.33%, significantly higher than that of the control group which was only 36.67%. Their differences have statistical significance (P 0.05). This study shows better clinical curative effect of high doses of levofloxacin treating lower respiratory infection with minimum risk. This method, which can significantly improve the quality of patient treatment with low adverse reaction risk, is worth popularizing in clinical use. Alreshidi et al., International Current Pharmaceutical Journal, November 2015, 4(12): 462-464","PeriodicalId":13811,"journal":{"name":"International Current Pharmaceutical Journal","volume":"88 1","pages":"462-464"},"PeriodicalIF":0.0000,"publicationDate":"2015-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Current Pharmaceutical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3329/ICPJ.V4I12.25598","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective of the current study was to investigate the effectiveness and safety of levofloxacin in the treatment of lower respiratory tract infection. The study was carried out in hospital on 120 patients with lower respiratory tract infection from January 2014 to January 2015. Patients were randomly divided into control and observation groups, each group contained 60 patients. The control group was given the routine dose of levofloxacin, whereas the observation group received the high dose of levofloxacin. The clinical effectiveness and incidence rate of untoward reactions between the two groups were statistically analyzed and evaluated. Patients’ cure rate in the observation group was 53.33%, significantly higher than that of the control group which was only 36.67%. Their differences have statistical significance (P 0.05). This study shows better clinical curative effect of high doses of levofloxacin treating lower respiratory infection with minimum risk. This method, which can significantly improve the quality of patient treatment with low adverse reaction risk, is worth popularizing in clinical use. Alreshidi et al., International Current Pharmaceutical Journal, November 2015, 4(12): 462-464
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
左氧氟沙星治疗下呼吸道感染的有效性和安全性分析。
本研究旨在探讨左氧氟沙星治疗下呼吸道感染的有效性和安全性。对2014年1月至2015年1月住院的120例下呼吸道感染患者进行研究。将患者随机分为对照组和观察组,每组60例。对照组给予常规剂量左氧氟沙星治疗,观察组给予大剂量左氧氟沙星治疗。对两组患者的临床疗效及不良反应发生率进行统计分析和评价。观察组患者治愈率为53.33%,显著高于对照组的36.67%。差异有统计学意义(p0.05)。本研究显示,大剂量左氧氟沙星治疗下呼吸道感染的临床疗效较好,且风险最小。该方法可显著提高患者治疗质量,不良反应风险低,值得在临床推广使用。Alreshidi等,国际药学杂志,2015,4(12):462-464
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Profilistic Study of Bioactivities of Extracts of Gongronema latifolium Incorporated with Alum on some Clinical Bacteria Updates on Approaches to Increase the Residence Time of Drug in the Stomach for Site Specific Delivery: Brief Review Formulation and investigation of crushed puffed rice-chitosan-HPMC based polymeric blends as carrier for sustained stomach specific drug delivery of piroxicam using 3(2) Taguchi mathematical design studies Quantitative Determination of thymoquinone in Nigella Sativa and its nano formulation using validated stability indicating HPTLC densiometric method Sterols from the fruit barks of Coelocaryon klainei Pierre ex Heckel (Myristicaceae)
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1